Neutrophil–lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry
DOI:
10.1007/s11739-025-03955-x
Publication Date:
2025-05-20T13:25:09Z
AUTHORS (140)
ABSTRACT
Liver cirrhosis (LC) is a leading global cause of morbidity and mortality, with inflammation playing key role in disease progression clinical complications LC. The Neutrophil/Lymphocyte Ratio (NLR), readily available marker systemic inflammation, has been linked to short-term adverse outcomes LC, but data on long-term follow-up are limited. This study aimed investigate the relationship between NLR all-cause mortality an unselected cohort LC patients. Data were gathered from Italian multicenter observational "PRO-LIVER". Patients calculate at baseline included. Baseline determinants association NRL 2-year evaluated. From overall (n = 753), 506 patients (31% female, mean age 64.8 ± 11.9 years) included analysis. Median value was 2.42 (Interquartile Range [IQR]: 1.61-3.52). At baseline, ≥ more likely have Child-Pugh B or C, hepatocellular carcinoma (HCC), portal vein thrombosis (PVT). After median 21 months, 129 died: 44 (17%) < 85 (34%) (p 0.001). multiple-adjusted Cox regression analysis, independently associated (HR: 1.65; 95% CI: 1.12-2.44; p 0.012), along age, C class, HCC PVT. may serve as potentially easily tool aid risk refinement ClinicalTrials.gov Identifier: NCT01470547.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....